Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRKAA2 encodes the catalytic alpha 2 subunit of AMP-activated protein kinase (AMPK), a heterotrimeric enzyme that acts as a central energy sensor in cells. Activated in response to metabolic stress or low cellular energy, AMPK phosphorylates and inactivates key enzymes involved in lipid and cholesterol biosynthesis. It plays a crucial role in glucose homeostasis, insulin sensitivity, and myocardial energy homeostasis. It also acts as a suppressor of endoplasmic reticulum stress. Its role in hepatoblastoma is complex, functioning as a tumor-promoting factor and implicated in ferroptosis regulation.
Kinase inhibitor; Activator of AMPK signaling pathway
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AMP-activated protein kinase catalytic subunit alpha 2 (PRKAA2).